Tear trough filler is an injectable treatment used to soften the hollow beneath the inner part of the lower eyelid1. This page focuses on hyaluronic acid, or HA, filler, which adds volume to improve the contour between the lower eyelid and cheek1.
For someone considering under eye filler in Singapore, the starting point is identifying the feature they would like to change. Explain whether your concern is a hollow, darkness, puffiness or a combination, rather than deciding on an injection before the assessment.


People with a defined hollow, minimal skin laxity and little protruding fat are generally better candidates than those with substantial puffiness or loose skin2. Existing swelling, very thin skin and previous filler can complicate treatment or make another approach more appropriate2.
Assessment should consider skin thickness, pigmentation, cheek volume and the contour of the lower eyelid3. Share your medical history, medicines, allergies and previous injections, including treatments performed elsewhere4.
Tell the doctor about fluctuating puffiness and any previous reaction to filler1. Pregnancy, breastfeeding and active infection or inflammation also need to be discussed before an elective procedure is considered1.

Filler may reduce shadowing caused by a hollow, while pigmentation and visible blood vessels require their own assessment3. Adding volume does not remove protruding orbital fat, although filling an adjacent hollow can make a small eye bag less noticeable in selected patients2.
Our guide to eye bags and their treatment options explains these different contributors to under eye fullness. Dr Rachel Ho’s article on eye bags and under eye hollowing discusses the wider treatment decisions.
Cheek volume contributes to the transition beneath the lower eyelid, so assessment should consider both areas3. In selected patients, addressing deficient cheek volume may improve this transition before direct tear trough treatment is considered3.
The recommendation should explain which area needs attention and why. Our guide to cheek fillers in Singapore provides background on cheek contouring without assuming that everyone needs treatment in both areas.

Treatment begins with assessment, discussion of the proposed benefits, alternatives and risks, and informed consent4. The skin is cleansed and the treatment area is planned before injections begin4.
A fine needle or cannula is used to place the selected HA preparation into the tissues beneath the skin1. Numbing may be used, although discomfort, pressure or tenderness can still occur1,5.
Ask which preparation is proposed and why it suits the area being assessed. Before leaving, obtain written aftercare instructions and confirm how to contact the treating clinician if symptoms develop4.
The depth and extent of the hollow, skin quality and tendency to swell influence the amount considered appropriate1. A proposed 0.5 ml or 1 ml describes a volume, rather than a standard result.
Clarify whether the amount covers one side or both, and what change it is intended to achieve. Ask how the need for any additional treatment would be assessed after the initial response.
A 2024 randomised trial involving 333 adults compared one HA preparation with an initially untreated control group5. At three months, 87.4% of treated participants achieved at least one grade of improvement in hollow severity on both sides, compared with 17.7% of controls, according to a blinded evaluator5.
The trial was funded by the manufacturer and allowed an additional treatment at one month5. Its findings support the particular preparation, protocol and selected patient population, rather than an identical outcome with every under eye filler5.
HA filler provides a temporary change rather than permanent augmentation1. In the trial above, 63.5% of treated participants still met the improvement threshold at twelve months5.
That finding describes the study group rather than a fixed date when everyone needs another injection. Reassessment should consider the remaining contour and any swelling before further treatment is discussed2.
Swelling, bruising, tenderness and firmness can occur after under eye filler injections5. The early appearance includes the tissue’s response to treatment, so immediate fullness should be distinguished from the contour assessed after recovery4.
Published expert consensus recommends review at approximately two to four weeks for patients receiving filler in a new treatment area4. Symptoms that are worsening or unexpected should be assessed earlier rather than saved for that appointment4.
Our guide to tear trough filler recovery covers swelling, lumps and the symptoms that need review day by day.
Expert consensus advises avoiding strenuous exercise for the first twenty four hours and avoiding rubbing or massage unless directed by the clinician4. These are consensus recommendations rather than a recovery schedule proven to suit every preparation and patient4.
Follow the instructions supplied for your procedure and clarify how they apply to your usual activities. Leave persistent lumps or unevenness for clinical assessment rather than trying to reshape the area yourself4.

The lower eyelid and upper cheek contain lymphatic pathways that drain fluid, and filler can interfere with that drainage2. Persistent swelling around the upper cheek is sometimes described as malar oedema2.
Delayed swelling and inflammatory nodules can also appear after an area initially seems to have settled9. A painful, red or enlarging lump needs prompt assessment because inflammation, infection and product related problems require different responses9.
A review should include previous cheek and tear trough injections, even when they were performed some time ago2. Puffiness alone is insufficient to establish that filler has migrated or that dissolving treatment is necessary2,9.

Possible complications include an uneven contour, visible lumps, persistent swelling and a blue grey discolouration associated with superficial filler2. Infection and delayed inflammatory reactions can also occur9.
A serious complication occurs when filler obstructs blood supply, potentially causing skin injury or tissue loss7. Vascular occlusion has been reported with both needles and cannulas, so either technique requires appropriate precautions6.
Increasing pain or skin that becomes unusually pale, dusky or mottled requires immediate medical assessment7. Significant pain may be absent early in a vascular complication, so concerning colour changes deserve attention even when the area feels relatively comfortable7.
Sudden blurred vision, loss of vision or new neurological symptoms after a facial filler injection require emergency care8. Call 995 in Singapore for emergency assistance rather than waiting for a routine clinic appointment8,10.
Hyaluronidase is an enzyme used by clinicians to break down HA filler in selected circumstances9. It may be considered for unwanted fullness, some lumps or persistent swelling, after the material and cause of the problem have been assessed9.
More than one treatment may be required, and hyaluronidase can cause adverse reactions, including allergy9. The ability to dissolve HA does not guarantee reversal of tissue injury or visual loss caused by a vascular complication8,9.
Read Dr Rachel Ho’s explanation of dissolving fillers with hyaluronidase for further detail. The assessment should come before a decision to dissolve or add more filler.
Treatment may instead focus on pigmentation, skin quality or another contributor to the under eye appearance3. Significant protruding fat and excess skin may warrant a surgical opinion, as these features can limit what adding volume achieves2.
Ask what each alternative would address and what it would leave unchanged. Choosing to leave the appearance alone is also reasonable when the expected benefit does not justify a procedure for you.
Collagen biostimulators are also used around the under eye area. A 2025 case report in Cureus used ultrasound and radiological imaging to assess PDLLA (Juvelook) for collagen stimulation and tear trough enhancement, although a single case cannot establish efficacy or safety11.
Request a quotation after assessment that identifies the proposed material and amount, including whether it covers one side or both. Clarify consultation fees, GST, aftercare, planned reviews and how additional assessment or correction would be handled.
Our article on what to expect at your first aesthetic consultation includes questions about treatment planning and ongoing care. Compare the complete proposal rather than the syringe price alone.
The clinic’s published under eye assessment considers fat prominence, fluid, skin thickness, laxity, tear trough depth and cheek support. This provides a starting point for discussing whether the concern is suited to filler or another approach.
Dr Rachel Ho is an aesthetic doctor and the founder of The Skin Longevity Clinic. Her professional profile outlines her qualifications and clinical background.
The clinic is located at Scotts Medical Center, 9 Scotts Road, Singapore 228210. Use the contact page to arrange an assessment and confirm current appointment arrangements.
Anido J, Fernández JM, Genol I, Ribé N, Pérez Sevilla G. Recommendations for the treatment of tear trough deformity with crosslinked hyaluronic acid filler. Journal of Cosmetic Dermatology. 2021;20(1):6 to 17.
Woodward J, Cox SE, Kato K, et al. Infraorbital Hollow Rejuvenation: Considerations, Complications, and the Contributions of Midface Volumization. Aesthetic Surgery Journal Open Forum. 2023;5:ojad016.
Liew S, Doreian S, Kunathathorn W, et al. Lower Eyelid Dark Circles: A Stepwise Assessment Framework. Aesthetic Surgery Journal. 2024;44(7):NP476 to NP485.
Goodman GJ, Liew S, Callan P, Hart S. Facial aesthetic injections in clinical practice: Pretreatment and posttreatment consensus recommendations to minimise adverse outcomes. Australasian Journal of Dermatology. 2020;61(3):217 to 225.
Biesman BS, Green JB, George R, et al. A Multicenter, Randomized, Evaluator Blinded Study to Examine the Safety and Effectiveness of Hyaluronic Acid Filler in the Correction of Infraorbital Hollows. Aesthetic Surgery Journal. 2024;44(9):1001 to 1013.
Alam M, Kakar R, Dover JS, et al. Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection. JAMA Dermatology. 2021;157(2):174 to 180.
Murray G, Convery C, Walker L, Davies E. Guideline for the Management of Hyaluronic Acid Filler Induced Vascular Occlusion. Journal of Clinical and Aesthetic Dermatology. 2021;14(5):E61 to E69.
Sansome S, Clague M, Convery C, et al. Consensus Guidelines for the Management of Tissue Filler Induced Vision Loss in the United Kingdom. Aesthetic Surgery Journal. 2026;46(5):563 to 568.
Kroumpouzos G, Treacy P. Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatology. 2024;7:e50403.
Singapore Civil Defence Force. Emergency Medical Services.
Ravera K. Ultrasound and Radiological Patterns in Assessing the Efficacy of Juvelook for Collagen Stimulation and Tear Trough Enhancement: A Case Report. Cureus. 2025;17(4):e82668. doi:10.7759/cureus.82668.